Results

Total Results: 3,152 records

Showing results for "colorectal cancer".
Users also searched for: colonoscopy

  1. digital.ahrq.gov/ahrq-funded-projects/economic-analysis-it-assisted-population-based-cancer-screening-program/annual-summary/2012
    January 01, 2012 - identification, individualized outreach, and subsequent tracking of patients overdue for breast, cervical, and colorectalcancer screening. … with primary care providers’ knowledge of their patients, yield improvements in breast, cervical, and colorectalcancer screening rates.
  2. digital.ahrq.gov/ahrq-funded-projects/economic-analysis-it-assisted-population-based-cancer-screening-program/annual-summary/2011
    January 01, 2011 - identification, individualized outreach, and subsequent tracking of patients overdue for breast, cervical, and colorectalcancer screening. … primary care providers' unique knowledge of their patients, yield improvements in breast, cervical, and colorectalcancer screening rates.
  3. www.ahrq.gov/research/findings/evidence-based-reports/search.html?page=33
    March 01, 2007 - 38 … next › ›› last » Last » Hereditary Nonpolyposis ColorectalCancer: Diagnostic Strategies and Their Implications Date: March 2007 Report Type: Evidence Reports … Affiliation: Tufts University Report Status: Final Use of Aspirin and NSAIDs to Prevent ColorectalCancer Date: March 2007 Report Type: U.S.
  4. psnet.ahrq.gov/issue/missed-and-delayed-diagnoses-ambulatory-setting-study-closed-malpractice-claims
    October 26, 2010 - Cognitive errors and logistical breakdowns contributing to missed and delayed diagnoses of breast and colorectalcancers: a process analysis of closed malpractice claims. … Cognitive errors and logistical breakdowns contributing to missed and delayed diagnoses of breast and colorectalcancers: a process analysis of closed malpractice claims.
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/disparities-quality-improvement_executive.pdf
    August 01, 2012 - BP = blood pressure; CRC = colorectal cancer; DBP = diastolic blood pressure; GAP = American College … CRC = colorectal cancer; QI = quality improvement; RCT = randomized controlled trial. … The patient navigator intervention was associated with increased colorectal cancer screening among … CRC = colorectal cancer; QI = quality improvement; RCT = randomized controlled trial. Table D. … cancer,18,20,21 and one assessing both breast and colorectal cancer screening.15 Disparities that
  6. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/disparities-quality-improvement_executive.pdf
    August 01, 2012 - BP = blood pressure; CRC = colorectal cancer; DBP = diastolic blood pressure; GAP = American College … CRC = colorectal cancer; QI = quality improvement; RCT = randomized controlled trial. … The patient navigator intervention was associated with increased colorectal cancer screening among … CRC = colorectal cancer; QI = quality improvement; RCT = randomized controlled trial. Table D. … cancer,18,20,21 and one assessing both breast and colorectal cancer screening.15 Disparities that
  7. effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-patients-with-rectal-cancer-what-is-the-comparative-effectiveness-of-different-imaging-modalities-alone-or-in-combination-ie-incremental-benefit-from-using-more-than-one-modality-for-preoperative-staging-and-treatment-sel
    June 01, 2011 - Among all racial groups in the United States, African Americans have the highest sporadic colorectalcancer incidence and mortality rates.* * It is difficult to separate epidemiological considerations … those of colon cancer because epidemiological studies often consider colon and rectal cancer (i.e., colorectalcancer) together (National Cancer Institute (PDQ®).
  8. digital.ahrq.gov/ahrq-funded-projects/technology-optimizing-population-care-resource-limited-environment/annual-summary/2012
    January 01, 2012 - analysis for this study is on the average screening test completion rates for breast, cervical, and colorectalcancers.
  9. www.uspreventiveservicestaskforce.org/uspstf/individualizing-cancer-screening-older-adults
    October 01, 2017 - Today, he presents for an annual checkup; you note that he has never had colorectal cancer screening. … Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement.  … Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. … Screening for Colorectal Cancer: An Updated Systematic Review. Evidence Synthesis No. 65.1. … Impact of age and comorbidity on colorectal cancer screening among older veterans. 
  10. digital.ahrq.gov/ahrq-funded-projects/measuring-and-improving-ambulatory-patient-safety-electronic-dashboard/annual-summary/2012
    January 01, 2012 - safety metrics across high-priority safety problems including anti-coagulation monitoring, abnormal colorectalcancer screening, and heart failure admission followup. … For abnormal colorectal cancer screening, the team has completed the registry and clinic workflow mapping
  11. www.cpsi.ahrq.gov/sites/default/files/wysiwyg/evidencenow/heart-health/aspirin-asa-measure.pptx
    April 01, 2016 - USPSTF recommends low-dose aspirin use for the primary prevention of cardiovascular disease (CVD) and colorectalcancer in adults ages 50 to 59 years who have a 10% or greater 10-year CVD risk, are not at increased … B Adults ages 60 to 69 years The decision to use low-dose aspirin to prevent CVD and colorectal cancercancer in adults younger than age 50 years. … cancer in adults age 70 years and older I 13 Aspirin and Antiplatelet Drugs in IVD—Work Flow Drugs
  12. www.innovations.ahrq.gov/sites/default/files/wysiwyg/evidencenow/heart-health/aspirin-asa-measure.pptx
    April 01, 2016 - USPSTF recommends low-dose aspirin use for the primary prevention of cardiovascular disease (CVD) and colorectalcancer in adults ages 50 to 59 years who have a 10% or greater 10-year CVD risk, are not at increased … B Adults ages 60 to 69 years The decision to use low-dose aspirin to prevent CVD and colorectal cancercancer in adults younger than age 50 years. … cancer in adults age 70 years and older I 13 Aspirin and Antiplatelet Drugs in IVD—Work Flow Drugs
  13. www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/evidencenow/heart-health/aspirin-asa-measure.pptx
    April 01, 2016 - USPSTF recommends low-dose aspirin use for the primary prevention of cardiovascular disease (CVD) and colorectalcancer in adults ages 50 to 59 years who have a 10% or greater 10-year CVD risk, are not at increased … B Adults ages 60 to 69 years The decision to use low-dose aspirin to prevent CVD and colorectal cancercancer in adults younger than age 50 years. … cancer in adults age 70 years and older I 13 Aspirin and Antiplatelet Drugs in IVD—Work Flow Drugs
  14. www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/evidencenow/heart-health/aspirin-asa-measure.pptx
    April 01, 2016 - USPSTF recommends low-dose aspirin use for the primary prevention of cardiovascular disease (CVD) and colorectalcancer in adults ages 50 to 59 years who have a 10% or greater 10-year CVD risk, are not at increased … B Adults ages 60 to 69 years The decision to use low-dose aspirin to prevent CVD and colorectal cancercancer in adults younger than age 50 years. … cancer in adults age 70 years and older I 13 Aspirin and Antiplatelet Drugs in IVD—Work Flow Drugs
  15. www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/evidencenow/heart-health/aspirin-asa-measure.pptx
    April 01, 2016 - USPSTF recommends low-dose aspirin use for the primary prevention of cardiovascular disease (CVD) and colorectalcancer in adults ages 50 to 59 years who have a 10% or greater 10-year CVD risk, are not at increased … B Adults ages 60 to 69 years The decision to use low-dose aspirin to prevent CVD and colorectal cancercancer in adults younger than age 50 years. … cancer in adults age 70 years and older I 13 Aspirin and Antiplatelet Drugs in IVD—Work Flow Drugs
  16. www.monahrq.ahrq.gov/sites/default/files/wysiwyg/evidencenow/heart-health/aspirin-asa-measure.pptx
    April 01, 2016 - USPSTF recommends low-dose aspirin use for the primary prevention of cardiovascular disease (CVD) and colorectalcancer in adults ages 50 to 59 years who have a 10% or greater 10-year CVD risk, are not at increased … B Adults ages 60 to 69 years The decision to use low-dose aspirin to prevent CVD and colorectal cancercancer in adults younger than age 50 years. … cancer in adults age 70 years and older I 13 Aspirin and Antiplatelet Drugs in IVD—Work Flow Drugs
  17. pbrn.ahrq.gov/sites/default/files/wysiwyg/evidencenow/heart-health/aspirin-asa-measure.pptx
    April 01, 2016 - USPSTF recommends low-dose aspirin use for the primary prevention of cardiovascular disease (CVD) and colorectalcancer in adults ages 50 to 59 years who have a 10% or greater 10-year CVD risk, are not at increased … B Adults ages 60 to 69 years The decision to use low-dose aspirin to prevent CVD and colorectal cancercancer in adults younger than age 50 years. … cancer in adults age 70 years and older I 13 Aspirin and Antiplatelet Drugs in IVD—Work Flow Drugs
  18. pcmh.ahrq.gov/sites/default/files/wysiwyg/evidencenow/heart-health/aspirin-asa-measure.pptx
    April 01, 2016 - USPSTF recommends low-dose aspirin use for the primary prevention of cardiovascular disease (CVD) and colorectalcancer in adults ages 50 to 59 years who have a 10% or greater 10-year CVD risk, are not at increased … B Adults ages 60 to 69 years The decision to use low-dose aspirin to prevent CVD and colorectal cancercancer in adults younger than age 50 years. … cancer in adults age 70 years and older I 13 Aspirin and Antiplatelet Drugs in IVD—Work Flow Drugs
  19. healthcare411.ahrq.gov/sites/default/files/wysiwyg/evidencenow/heart-health/aspirin-asa-measure.pptx
    April 01, 2016 - USPSTF recommends low-dose aspirin use for the primary prevention of cardiovascular disease (CVD) and colorectalcancer in adults ages 50 to 59 years who have a 10% or greater 10-year CVD risk, are not at increased … B Adults ages 60 to 69 years The decision to use low-dose aspirin to prevent CVD and colorectal cancercancer in adults younger than age 50 years. … cancer in adults age 70 years and older I 13 Aspirin and Antiplatelet Drugs in IVD—Work Flow Drugs
  20. cahps.ahrq.gov/sites/default/files/wysiwyg/evidencenow/heart-health/aspirin-asa-measure.pptx
    April 01, 2016 - USPSTF recommends low-dose aspirin use for the primary prevention of cardiovascular disease (CVD) and colorectalcancer in adults ages 50 to 59 years who have a 10% or greater 10-year CVD risk, are not at increased … B Adults ages 60 to 69 years The decision to use low-dose aspirin to prevent CVD and colorectal cancercancer in adults younger than age 50 years. … cancer in adults age 70 years and older I 13 Aspirin and Antiplatelet Drugs in IVD—Work Flow Drugs